RLM.L Regulatory News (RLM)

25 Oct 2007 07:00

PuriCore Plc25 October 2007 PuriCore presenting at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 25 October 2007 - PuriCore (LSE: PURI),the life sciences company focused on the development and commercialisation ofits novel, safe antimicrobial technology, today announces that its ChiefExecutive Officer, Greg Bosch, will be presenting at the Acumen BioFin Rodman &Renshaw 9th Annual Healthcare Conference at the New York Palace Hotel in NewYork, New York, on 5 November 2007. A live webcast of the presentation will beavailable as at 4:05 p.m. EST on Monday, 5 November 2007, at http://www.wsw.com/webcast/rrshq12/puri.ln. About PuriCore PuriCore (LSE: PURI) is a life sciences company focused on developing andcommercialising proprietary products that safely, effectively, and naturallykill contagious pathogens. PuriCore's technology provides a solution to a broadrange of markets that depend upon controlling contamination, including foodsafety in retail and foodservice, medical device disinfection, wound therapy,and hospitality. The Company's proprietary technology mimics the human body'sproduction of the natural antimicrobial hypochlorous acid, which is highlyeffective in killing bacteria, viruses, and fungal spores. Deployinghypochlorous acid solutions as soaks, sprays, mists, and in other forms,PuriCore's technology is designed to limit the spread of infectious disease,including major public health threats of M. tuberculosis, MRSA, E.coli,Norovirus, Avian Influenza, HIV, Polio Virus, Helicobater pylori, andLegionella. PuriCore is headquartered in Malvern, Pennsylvania, with offices inStafford, UK. To receive additional information on PuriCore, please visit our website atwww.puricore.com, which does not form part of this press release. Certain statements made in this announcement are forward-looking statements.These forward-looking statements are not historical facts but rather are basedon the Company's current expectations, estimates, and projections about itsindustry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,''intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressionsare intended to identify forward-looking statements. These statements are notguarantees of future performance and are subject to known and unknown risks,uncertainties, and other factors, some of which are beyond the Company'scontrol, are difficult to predict, and could cause actual results to differmaterially from those expressed or forecasted in the forward-looking statements.The Company cautions shareholders and prospective shareholders not to placeundue reliance on these forward-looking statements, which reflect the view ofthe Company only as of the date of this announcement. The forward-lookingstatements made in this announcement relate only to events as of the date onwhich the statements are made. The Company will not undertake any obligation torelease publicly any revisions or updates to these forward-looking statements toreflect events, circumstances, or unanticipated events occurring after the dateof this announcement except as required by law or by any appropriate regulatoryauthority. Contacts:Ben Brewerton Greg Bosch, CEOFinancial Dynamics Keith A. Goldan, CFO+44 (0)20 7269 7279 PuriCore +1 484 321 2700 This information is provided by RNS The company news service from the London Stock Exchange